Description
Sanofi is a R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.
Role with PROBE
Sanofi is a global healthcare leader with a strong focus on immunology and inflammation, making it well-suited for the IHI project on osteoarthritis (OA) endpoint development. Sanofi's expertise in big data analytics and AI integration supports the project's goals of identifying OA patient subpopulations and predicting disease progression. Additionally, their patient-centered approach and experience in developing patient-reported outcomes align with the project's aim to create novel endpoints reflecting real-life treatment benefits. Sanofi's collaborative spirit and regulatory experience further enhance their ability to contribute effectively to this initiative.
